Back
Akebia Therapeutics Vs. Core & Main Industry Stock Comparison
Buy
66
AKBA
Akebia Therapeutics
Last Price:
2.04
Seasonality Move:
28.83%
Sell
41
CNM
Core & Main
Last Price:
55.26
Seasonality Move:
11.77%
Buy
66
Akebia Therapeutics (AKBA)
is a Buy
Is Akebia Therapeutics a Buy, Sell or Hold?
- The current Akebia Therapeutics [AKBA] share price is $2.04. The Score for AKBA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Core & Main (CNM)
is a Sell
Is Core & Main a Buy, Sell or Hold?
- The current Core & Main [CNM] share price is $55.78. The Score for CNM is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- CNM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKBA Stock Price Chart
What is Akebia Therapeutics's stock price today?
-
The Akebia Therapeutics share price today is $2.04
The current trend is moderately bullish and AKBA is experiencing selling pressure, which indicates risk of future bearish movement.
CNM Stock Price Chart
What is Core & Main's stock price today?
-
The Core & Main share price today is $55.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNM is experiencing slight buying pressure.
AKBA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 64.07 | Buy |
| Chaikin Money Flow: | -2084803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.76 - 2.02) | Buy |
| Bollinger Bands (100): | (1.26 - 1.76) | Buy |
CNM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.56 | Buy |
| Relative Strength Index (14 RSI): | 79.68 | Buy |
| Chaikin Money Flow: | 2765950 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.46 - 48.16) | Buy |
| Bollinger Bands (100): | (42.36 - 50.56) | Buy |
AKBA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2 | Buy |
| 20-day SMA: | 1.93 | Buy |
| 50-day SMA: | 1.63 | Buy |
| 200-day SMA: | 1.43 | Buy |
| 8-day EMA: | 2.01 | Buy |
| 20-day EMA: | 1.91 | Buy |
| 50-day EMA: | 1.72 | Buy |
| 200-day EMA: | 1.45 | Buy |
CNM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.03 | Buy |
| 20-day SMA: | 45.56 | Buy |
| 50-day SMA: | 44.97 | Buy |
| 200-day SMA: | 50.06 | Buy |
| 8-day EMA: | 48.84 | Buy |
| 20-day EMA: | 46.59 | Buy |
| 50-day EMA: | 45.7 | Buy |
| 200-day EMA: | 46.09 | Buy |
Akebia Therapeutics Earnings Growth & AKBA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.07 per share.
Core & Main Earnings Growth & CNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.33 per share, an increase this year of $0.06 per share, and a decrease next year of $0.07 per share.
Akebia Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Core & Main Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||